The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for BioGX sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData


Data Insights BioGX Inc, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

BioGX is a molecular diagnostic solutions company that provides an array of molecular diagnostics testing solutions. It develops innovative molecular diagnostics solutions to advance healthcare. It develops molecular assays and reagents that cater to various applications, including infectious diseases. Its open source reagents (OSRs) manufacturing service offers laboratories an excellent option to outsource manufacturing of their Laboratory Developed Tests (LDTs). The company’s sample-ready reagents are CE-IVD marked and lyophilized in a single tube enabling labs to run fast, accurate, and efficient RT-PCR tests. BioGX is headquartered in Birmingham, Alabama, the US. Key subsidiaries of BioGX include BioGX.

The key metrics of BioGX related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:

As BioGX is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as BioGX.

For a detailed understanding of the performance of BioGX, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.